Deutsch English Français

Contact

EP1009413

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP1009413

EP1009413 - USE OF IMMUNOSTIMULATORY OLIGONUCLEOTIDES FOR PREVENTING OR TREATING ASTHMA [Right-click to bookmark this link]
Former [2000/25]	USE OF IMMUNOSTIMULATORY OLIGONUCLEOTIDES FOR PREVENTING OR REDUCING ANTIGEN-STIMULATED, GRANULOCYTE-MEDIATED INFLAMMATION
	[2006/33]
Status	Patent revoked Status updated on 06.03.2015 Database last updated on 16.09.2024
Most recent event Tooltip	10.04.2015	Lapse of the patent in a contracting state	published on 13.05.2015 [2015/20]
Applicant(s)	For all designated states The Regents of the University of California 1111 Franklin Street, 12th Floor Oakland, CA 94607 / US
	[N/P]
Former [2007/07]	For all designated states The Regents of the University of California 12th Floor, 1111 Franklin Street Oakland California 94607-5200 / US
Former [2000/25]	For all designated states THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 12th Floor, 1111 Franklin Street Oakland, California 94607-5200 / US
Inventor(s)	01 / RAZ, Eyal 13658 Mango Drive Del Mar, CA 92014 / US
	[2000/25]
Representative(s)	Brasnett, Adrian Hugh, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB
	[N/P]
Former [2000/25]	Brasnett, Adrian Hugh, et al Mewburn Ellis York House 23 Kingsway London WC2B 6HP / GB
Application number, filing date	98945877.3	04.09.1998
	[2000/25]
	WO1998US18382
Priority number, date	US19970927120	05.09.1997 Original published format: US 927120
	[2000/25]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO9911275
	Date:	11.03.1999
	Language:	EN
	[1999/10]
	Type:	A2 Application without search report
	No.:	EP1009413
	Date:	21.06.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 11.03.1999 takes the place of the publication of the European patent application.
	[2000/25]
	Type:	B1 Patent specification
	No.:	EP1009413
	Date:	14.02.2007
	Language:	EN
	[2007/07]
Search report(s)	International search report - published on:	EP	03.06.1999
Classification	IPC:	A61K31/70, A61K39/385, A61P11/06	[2006/33]
	CPC:	A61K39/35 (EP,US); A61P11/06 (EP); A61P21/00 (EP); A61P27/02 (EP); A61P27/16 (EP); A61P29/00 (EP); (+) A61P37/02 (EP); A61P37/08 (EP); A61K2039/53 (EP,US); A61K2039/543 (EP,US); A61K2039/55561 (EP,US) (-)
	Former IPC [2000/25]	A61K31/70, A61K39/385
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/25]
Title	German:	VERWENDUNG VON IMMUNERREGENDEN OLIGONUKLEOTIDEN ZUR VORBEUGUNG ODER BEHANDLUNG VON ASTHMA	[2006/33]
	English:	USE OF IMMUNOSTIMULATORY OLIGONUCLEOTIDES FOR PREVENTING OR TREATING ASTHMA	[2006/33]
	French:	UTILISATION D'OLIGONUCLEOTIDES IMMUNOSTIMULANTS POUR LA PREVENTION OU LE TRAITMENT DE L'ASTHME	[2006/33]
	Former [2000/25]	VERWENDUNG VON IMMUNERREGENDEN OLIGONUKLEOTIDEN ZUR VORBEUGUNG OR REDUZIERUNG EINER ANTIGENERREGTEN, GRANULOZYTMEDIIERTEN ENTZÜNDUNG
	Former [2000/25]	USE OF IMMUNOSTIMULATORY OLIGONUCLEOTIDES FOR PREVENTING OR REDUCING ANTIGEN-STIMULATED, GRANULOCYTE-MEDIATED INFLAMMATION
	Former [2000/25]	UTILISATION D'OLIGONUCLEOTIDES IMMUNOSTIMULANTS POUR LA PREVENTION OU LA REDUCTION DES INFLAMMATIONS A MEDIATION GRANULOCYTAIRE ET STIMULEES PAR DES ANTIGENES
Entry into regional phase	31.03.2000	National basic fee paid
	31.03.2000	Designation fee(s) paid
	31.03.2000	Examination fee paid
Examination procedure	30.03.1999	Request for preliminary examination filed International Preliminary Examining Authority: EP
	31.03.2000	Amendment by applicant (claims and/or description)
	31.03.2000	Examination requested [2000/25]
	10.01.2002	Despatch of a communication from the examining division (Time limit: M06)
	16.07.2002	Reply to a communication from the examining division
	11.02.2003	Observations by third parties
	21.04.2004	Despatch of a communication from the examining division (Time limit: M04)
	22.04.2004	Reply to a communication from the examining division
	14.06.2004	Despatch of a communication from the examining division (Time limit: M06)
	17.12.2004	Reply to a communication from the examining division
	15.02.2005	Despatch of a communication from the examining division (Time limit: M06)
	09.08.2005	Reply to a communication from the examining division
	25.11.2005	Observations by third parties
	11.07.2006	Minutes of oral proceedings despatched
	17.07.2006	Date of oral proceedings
	25.08.2006	Communication of intention to grant the patent
	27.12.2006	Fee for grant paid
	27.12.2006	Fee for publishing/printing paid
Divisional application(s)	EP07001453.5 / EP1872786
Opposition(s)	Opponent(s)	01 13.11.2007 22.11.2007 ADMISSIBLE Cytos Biotechnology AG Wagistrasse 25 8952 Schlieren / CH Opponent's representative Wichmann, Hendrik Wuesthoff & Wuesthoff Patentanwälte und Rechtsanwalt PartG mbB Schweigerstraße 2 81541 München / DE
		02 14.11.2007 22.11.2007 ADMISSIBLE Coley Pharmaceutical Group, Inc. 93 Worcester Street, Suit 101, Wellesley MA 02481 / US Opponent's representative Jump, Timothy John Simon, et al, et al Venner Shipley LLP 200 Aldersgate London EC1A 4HD / GB
		[N/P]
	Former [2010/42]
	Opponent(s)	01 13.11.2007 22.11.2007 ADMISSIBLE Cytos Biotechnology AG Wagistrasse 25 8952 Schlieren / CH Opponent's representative Wichmann, Hendrik Wuesthoff & Wuesthoff Schweigstrasse 2 81541 München / DE
		02 14.11.2007 22.11.2007 ADMISSIBLE Coley Pharmaceutical Group, Inc. 93 Worcester Street, Suit 101, Wellesley MA 02481 / US Opponent's representative Jump, Timothy John Simon, et al, et al Venner Shipley LLP 20 Little Britain London EC1A 7DH / GB
	Former [2008/38]
	Opponent(s)	01 13.11.2007 22.11.2007 ADMISSIBLE Cytos Biotechnology AG Wagistrasse 25 8952 Schlieren / CH Opponent's representative Wichmann, Hendrik Isenbruck Bösl Hörschler Wichmann Huhn Patentanwälte Prinzregentenstrasse 68 81675 München / DE
		02 14.11.2007 22.11.2007 ADMISSIBLE Coley Pharmaceutical Group, Inc. 93 Worcester Street, Suit 101, Wellesley MA 02481 / US Opponent's representative Jump, Timothy John Simon, et al, et al Venner Shipley LLP 20 Little Britain London EC1A 7DH / GB
	Former [2007/51]
	Opponent(s)	01 13.11.2007 Cytos Biotechnology AG Wagistrasse 25 8952 Schlieren / CH Opponent's representative Wichmann, Hendrik Patentanwälte Isenbruck Bösl Hörschler Wichmann Huhn Postfach 86 08 80 81635 München / DE
		02 14.11.2007 Coley Pharmaceutical Group, Inc. 93 Worcester Street, Suit 101, Wellesley MA 02481 / US Opponent's representative Jump, Timothy John Simon, et al, et al Venner Shipley LLP 20 Little Britain London EC1A 7DH / GB
	20.12.2007	Invitation to proprietor to file observations on the notice of opposition
	01.09.2008	Reply of patent proprietor to notice(s) of opposition
	28.10.2009	Date of oral proceedings
	26.11.2009	Despatch of minutes of oral proceedings
	26.11.2009	Despatch of communication that the patent will be revoked
	13.02.2015	Legal effect of revocation of patent [2015/15]
Appeal following opposition	26.01.2010	Appeal received No. T0159/10
	31.03.2010	Statement of grounds filed
	13.02.2015	Result of appeal procedure: appeal of the proprietor withdrawn
Fees paid	Renewal fee
	28.08.2000	Renewal fee patent year 03
	24.09.2001	Renewal fee patent year 04
	23.09.2002	Renewal fee patent year 05
	24.09.2003	Renewal fee patent year 06
	23.09.2004	Renewal fee patent year 07
	21.09.2005	Renewal fee patent year 08
	27.09.2006	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CH	14.02.2007
	LI	14.02.2007
	[2015/20]
Cited in	International search	[X]EP0468520 (MITSUI TOATSU CHEMICALS [JP]) [X] 1-37 * page 2, line 23 - page 5, line 36 *;
		[XD]WO9728259 (UNIV CALIFORNIA [US]) [XD] 1-37 * page 11, line 5 - page 19, line 9 * * page 33, line 25 - page 47, line 15 *;
		[XPD]WO9816247 (UNIV CALIFORNIA [US], et al) [XPD] 1-37 * page 10, line 1 - page 21, line 14 *;
		[XP]WO9818810 (UNIV IOWA RES FOUND [US], et al) [XP] 1-37 * page 15, line 8 - page 67, line 9 *;
		[A] - JOURNAL OF IMMUNOLOGY., BALTIMORE US, (19920615), vol. 148, no. 12, pages 4072 - 4076, XP002098020 [A] * the whole document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p